ARKF vs IBB
ARK Fintech Innovation ETF vs iShares Biotechnology ETF
- • IBB has the lower expense ratio at 0.44% vs 0.75% for ARKF.
- • IBB pays a higher dividend yield (0.23%).
Side-by-side metrics
| Metric | ARKF | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.44% |
Dividend yield Trailing 12-month yield. | 0.10% | 0.23% |
AUM Assets under management — bigger funds are typically more liquid. | $828M | $7.95B |
YTD return | -10.39% | 3.10% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.06 | 0.74 |
P/E ratio | 36.52 | 23.72 |
Last price | $42.28 | $170.10 |
Inception | — | — |
Issuer | ARK | iShares |
ARKF top holdings
| SHOP | Shopify Inc Registered Shs -A- Subord Vtg | 9.27% |
| COIN | Coinbase Global Inc Ordinary Shares - Class A | 5.83% |
| CRCL | Circle Internet Group Inc Ordinary Shares - Class A | 5.47% |
| XYZ | Block Inc Class A | 5.31% |
| HOOD | Robinhood Markets Inc Class A | 4.47% |
| PLTR | Palantir Technologies Inc Ordinary Shares - Class A | 4.20% |
| TOST | Toast Inc Class A | 4.12% |
| AMD | Advanced Micro Devices Inc | 3.88% |
| AMZN | Amazon.com Inc | 3.87% |
IBB top holdings
| AMGN | Amgen Inc | 7.37% |
| GILD | Gilead Sciences Inc | 7.32% |
| VRTX | Vertex Pharmaceuticals Inc | 7.21% |
| REGN | Regeneron Pharmaceuticals Inc | 6.55% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.71% |
| ARGX | argenx SE ADR | 3.33% |
| INSM | Insmed Inc | 2.70% |
| BIIB | Biogen Inc | 2.67% |
| NTRA | Natera Inc | 2.40% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.27% |
About ARKF
ARKF (ARK Fintech Innovation ETF) is Fintech companies disrupting financial services. Managed by ARK, the fund carries $828M in assets under management, an expense ratio of 0.75%, a dividend yield of 0.10%. Its largest holding is Shopify Inc Registered Shs -A- Subord Vtg (SHOP), which represents 9.3% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 16.4%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.